News
Keep up with Ology Bioservices. Here’s our latest…
News
Ology Bioservices Strengthens Board of Directors
Ology Bioservices Strengthens Board of Directors with Appointment of Industry Veterans James M. Robinson and Gerard Cunningham Former Merck & Co. Executives Bring Deep Expertise in Development and Manufacturing of Vaccines and Biologicals [...]
Nanotherapeutics Announces Name Change to Ology Bioservices
Nanotherapeutics Announces Name Change to Ology Bioservices, Reflecting the Company’s Ongoing Transformation into One of the Top Contract Development and Manufacturing Organizations of Vaccines and Biologics ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, Inc. today announced [...]
Peter H. Khoury, Ph.D., MBA Appointed President and Chief Executive Officer of Nanotherapeutics
ALACHUA, Fla.--(BUSINESS WIRE)--Nanotherapeutics, Inc., a biologics focused contract development and manufacturing organization (CDMO), today announced that Peter H. Khoury, Ph.D., MBA, formerly Senior Vice President and Chief Commercial Officer, has been appointed President and Chief Executive Officer of the Company.
Nanotherapeutics Bohumil s.r.o. and Praha Vaccines a.s. Finalize Transfer of Human Vaccine Manufacturing Enterprise in the Czech Republic
ALACHUA, Fla. & PUNE, India--(BUSINESS WIRE)--Nanotherapeutics Bohumil s.r.o. (a wholly owned subsidiary of Nanotherapeutics, Inc.) and Cyrus Poonawalla Group announced today the final transfer of Nanotherapeutics Bohumil s.r.o.’s vaccine production enterprise located in [...]
Battelle and Nanotherapeutics Form Alliance to Accelerate Medical Countermeasures Development
Battelle and Nanotherapeutics, Inc. announced today that the organizations have entered an alliance to bring together core research, development, test and evaluation (RDT&E) and manufacturing capabilities needed to expedite the development of medical countermeasures urgently [...]
Trethera Corporation and Nanotherapeutics Sign Exclusive Worldwide Agreement for Rights to Triapine® in Hematological Malignancies
Trethera Corporation and Nanotherapeutics Sign Exclusive Worldwide Agreement for Rights to Triapine® in Hematological Malignancies SANTA MONICA, Calif. & ALACHUA, Fla.--(BUSINESS WIRE)--Trethera Corporation and Nanotherapeutics, Inc. today announced the signing of an [...]